Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Clinical Trials

4 clinical trials for Blasts More Than 5 Percent of Bone Marrow Nucleated Cells across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia — RECRUITING · PHASE1
• Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction — RECRUITING · PHASE1
• Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders — RECRUITING · PHASE2
• Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML — COMPLETED · PHASE1

Refine this search